NICE Yervoy, Invokana Rulings Show Need for Regulator/HTA Dialogue
NICE downgrades BMS’ Yervoy, while Janssen omits filing for all combinations for Invokana, underscoring the need for EU harmonization through HTA/regulator dialogue.
NICE downgrades BMS’ Yervoy, while Janssen omits filing for all combinations for Invokana, underscoring the need for EU harmonization through HTA/regulator dialogue.